| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |